Thienopyrazine inhibitors of IRAK4 activity
The present invention relates to thienopyrazine inhibitors of IRAK4 of formula (I) and provides compositions comprising such inhibitors, as well as methods therewith for treating IRAK4-mediated or -associated conditions or diseases.
1. A compound according to Formula I:
wherein:
Ring A is aryl or heterocyclyl;
n is 0, 1, 2, 3 or 4;
R 1 is independently selected from: (C 1 -C 4 )alkyl, (C 3 -C 6 )cycloalkyl, heterocyclyl, CN, halo, said alkyl, cycloalkyl and heterocyclyl optionally substituted with halo, OH, and OCH 3 ;
R 2 is H and R 3 is independently selected from: (C 1 -C 6 )alkyl, (C 3 -C 8 )cycloalkyl and heterocyclyl each optionally substituted with one or more halo, OH, N(R b ) 2 , or morpholinyl, or R 2 and R 3 can be taken together with the nitrogen to which they are attached to form a heterocyclyl, said heterocyclyl optionally substituted with one or more substituents selected from R a ;
R a is independently selected from (C 1 -C 4 )alkyl, (C 3 -C 6 )cycloalkyl, CF 3 , CHF 2 , OH, halo and NH 2 , said alkyl optionally substituted with (C 3 -C 6 )cycloalkyl and CF 3 ; and
R b is independently selected from H and (C 1 -C 4 )alkyl;
or a pharmaceutically acceptable salt thereof.
2. A compound according to claim 1 of Formula I:
wherein:
Ring A is pyrazolyl, pyridinyl, thiophenyl, furanyl or phenyl;
n is 0, 1 or 2;
R 1 is independently selected from: (C 1 -C 4 )alkyl, cyclopropyl, oxadiazolyl, pyridinyl, oxazolyl, triazolyl, pyriminidyl, CN and halo, said alkyl, oxadiazolyl, pyridinyl, oxazolyl, triazolyl and pyriminidyl are optionally substituted with halo, OH, and OCH 3 ;
R 2 is H and R 3 is independently selected from: (C 1 -C 4 )alkyl, cyclohexyl, cycloheptyl, piperidinyl and azepanyl each optionally substituted with one or more F, OH, N(R b ) 2 , or morpholinyl, or R 2 and R 3 can be taken together with the nitrogen to which they are attached to form a heterocyclyl selected from piperazinyl, diazepanyl, diazabicyclooctyl, diazabicycloheptyl, diazaspirononyl, hexahydropyrrolopyrazinyl, piperidinyl, diazabicyclononyl, oxadiazabicyclodecyl and diazatricyclodecyl, said heterocyclyl optionally substituted with one or more substituents selected from R a ;
R a is independently selected from (C 1 -C 4 )alkyl, cyclopropyl, CF 3 , CHF 2 , OH, F and NH 2 , said alkyl optionally substituted with cyclopropyl and CF 3 ; and
R b is independently selected from H and methyl;
or a pharmaceutically acceptable salt thereof.
3. A compound which is selected from:
2-{[(1R,2S)-2-aminocyclohexyl]amino}-N-[1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]thieno[2,3-b]pyrazine-7-carboxamide;
N-[1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]-2-piperazin-1-ylthieno[2,3-b]pyrazine-7-carboxamide;
2-{[(1R,2S)-2-hydroxycyclohexyl]amino}-N-[1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]thieno[2,3-b]pyrazine-7-carboxamide;
N-[1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]-2-[(3R)-piperidin-3-ylamino]thieno[2,3-b]pyrazine-7-carboxamide;
2-{[(1R,2R)-2-amino-3,3-difluorocyclohexyl]amino}-N-[1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]thieno[2,3-b]pyrazine-7-carboxamide;
2-(1,4-diazepan-1-yl)-N-[1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]thieno[2,3-b]pyrazine-7-carboxamide;
2-(2,5-diazabicyclo[2.2.2]oct-2-yl)-N-[1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]thieno[2,3-b]pyrazine-7-carboxamide;
2-(5,8-diazaspiro[2.6]non-5-yl)-N-[1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]thieno[2,3-b]pyrazine-7-carboxamide;
2-[(3R)-3-aminopiperidin-1-yl]-N-[1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]thieno[2,3-b]pyrazine-7-carboxamide;
N-[3-(difluoromethyl)-1-methyl-1H-pyrazol-4-yl]-2-{[(1R,2S)-2-hydroxycyclohexyl]amino}thieno[2,3-b]pyrazine-7-carboxamide;
2-(2,5-diazabicyclo[2.2.2]oct-2-yl)-N-[3-(difluoromethyl)-1-methyl-1H-pyrazol-4-yl]thieno[2,3-b]pyrazine-7-carboxamide;
N-[3-(difluoromethyl)-1-methyl-1H-pyrazol-4-yl]-2-piperazin-1-ylthieno[2,3-b]pyrazine-7-carboxamide;
2-(5,8-diazaspiro[2.6]non-5-yl)-N-[3-(difluoromethyl)-1-methyl-1H-pyrazol-4-yl]thieno[2,3-b]pyrazine-7-carboxamide;
2-(1,4-diazepan-1-yl)-N-[3-(difluoromethyl)-1-methyl-1H-pyrazol-4-yl]thieno[2,3-b]pyrazine-7-carboxamide;
2-(azepan-3-ylamino)-N-[1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]thieno[2,3-b]pyrazine-7-carboxamide;
N-(3-chloro-1-methyl-1H-pyrazol-4-yl)-2-[(1S,4S)-2,5-diazabicyclo[2.2.2]oct-2-yl]thieno[2,3-b]pyrazine-7-carboxamide;
N-(3-chloro-1-methyl-1H-pyrazol-4-yl)-2-[(1R,4R)-2,5-diazabicyclo[2.2.2]oct-2-yl]thieno[2,3-b]pyrazine-7-carboxamide;
N-(3-chloro-1-methyl-1H-pyrazol-4-yl)-2-(1,4-diazepan-1-yl)thieno[2,3-b]pyrazine-7-carboxamide;
N-(3-bromo-1-methyl-1H-pyrazol-4-yl)-2-[(1S,4S)-2,5-diazabicyclo[2.2.2]oct-2-yl]thieno[2,3-b]pyrazine-7-carboxamide;
N-(3-bromo-1-methyl-1H-pyrazol-4-yl)-2-[(1R,4R)-2,5-diazabicyclo[2.2.2]oct-2-yl]thieno[2,3-b]pyrazine-7-carboxamide;
N-(3-bromo-1-methyl-1H-pyrazol-4-yl)-2-(1,4-diazepan-1-yl)thieno[2,3-b]pyrazine-7-carboxamide;
2-[(1S,4S)-2,5-diazabicyclo[2.2.2]oct-2-yl]-N-[3-(difluoromethyl)-1-methyl-1H-pyrazol-4-yl]thieno[2,3-b]pyrazine-7-carboxamide;
2-[(1R,4R)-2,5-diazabicyclo[2.2.2]oct-2-yl]-N-[3-(difluoromethyl)-1-methyl-1H-pyrazol-4-yl]thieno[2,3-b]pyrazine-7-carboxamide;
2-[(3R)-3-aminopiperidin-1-yl]-N-[3-(difluoromethyl)-1-methyl-1H-pyrazol-4-yl]thieno[2,3-b]pyrazine-7-carboxamide;
2-{[(1R,2S)-2-aminocyclohexyl]amino}-N-[3-(difluoromethyl)-1-methyl-1H-pyrazol-4-yl]thieno[2,3-b]pyrazine-7-carboxamide;
N-(3-cyano-1-methyl-1H-pyrazol-4-yl)-2-[(1S,4S)-2,5-diazabicyclo[2.2.2]oct-2-yl]thieno[2,3-b]pyrazine-7-carboxamide;
N-(3-cyano-1-methyl-1H-pyrazol-4-yl)-2-[(1R,4R)-2,5-diazabicyclo[2.2.2]oct-2-yl]thieno[2,3-b]pyrazine-7-carboxamide;
N-(3-cyano-1-methyl-1H-pyrazol-4-yl)-2-(1,4-diazepan-1-yl)thieno[2,3-b]pyrazine-7-carboxamide;
2-{[(1R,2R)-2-amino-3,3-difluorocyclohexyl]amino}-N-(3-bromo-1-methyl-1H-pyrazol-4-yl)thieno[2,3-b]pyrazine-7-carboxamide;
2-{[(1R,2S)-2-aminocyclohexyl]amino}-N-(3-bromo-1-methyl-1H-pyrazol-4-yl)thieno[2,3-b]pyrazine-7-carboxamide;
2-[(3S)-azepan-3-ylamino]-N-[1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]thieno[2,3-b]pyrazine-7-carboxamide;
N-[3-(difluoromethyl)-1-methyl-1H-pyrazol-4-yl]-2-[(3R)-piperidin-3-ylamino]thieno[2,3-b]pyrazine-7-carboxamide;
2-[(3R)-azepan-3-ylamino]-N-[3-(difluoromethyl)-1-methyl-1H-pyrazol-4-yl]thieno[2,3-b]pyrazine-7-carboxamide;
2-[(3S)-azepan-3-ylamino]-N-[3-(difluoromethyl)-1-methyl-1H-pyrazol-4-yl]thieno[2,3-b]pyrazine-7-carboxamide;
2-{[(1R,2S)-2-aminocyclohexyl]amino}-N-(3-chloro-1-methyl-1H-pyrazol-4-yl)thieno[2,3-b]pyrazine-7-carboxamide;
2-{[(1R,2R)-2-amino-3,3-difluorocyclohexyl]amino}-N-(3-cyano-1-methyl-1H-pyrazol-4-yl)thieno[2,3-b]pyrazine-7-carboxamide;
2-{[(1R,2S)-2-aminocyclohexyl]amino}-N-(3-cyano-1-methyl-1H-pyrazol-4-yl)thieno[2,3-b]pyrazine-7-carboxamide;
2-[(3R)-azepan-3-ylamino]-N-[1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]thieno[2,3-b]pyrazine-7-carboxamide;
2-{[(1R,2R)-2-amino-3,3-difluorocyclohexyl]amino}-N-[3-(difluoromethyl)-1-methyl-1H-pyrazol-4-yl]thieno[2,3-b]pyrazine-7-carboxamide;
2-(3,8-diazabicyclo[3.2.1]oct-3-yl)-N-[3-(difluoromethyl)-1-methyl-1H-pyrazol-4-yl]thieno[2,3-b]pyrazine-7-carboxamide;
2-(3,8-diazabicyclo[3.2.1]oct-3-yl)-N-[1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]thieno[2,3-b]pyrazine-7-carboxamide;
2-{[(1R,2S)-2-aminocyclohexyl]amino}-N-[1-methyl-5-(trifluoromethyl)-1H-pyrazol-4-yl]thieno[2,3-b]pyrazine-7-carboxamide;
2-{[(1R,2R)-2-amino-3,3-difluorocyclohexyl]amino}-N-(3-chloro-1-methyl-1H-pyrazol-4-yl)thieno[2,3-b]pyrazine-7-carboxamide;
2-(3,8-diazabicyclo[3.2.1]oct-8-yl)-N-[3-(difluoromethyl)-1-methyl-1H-pyrazol-4-yl]thieno[2,3-b]pyrazine-7-carboxamide;
2-(3,8-diazabicyclo[3.2.1]oct-8-yl)-N-[1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]thieno[2,3-b]pyrazine-7-carboxamide;
N-(4-bromothiophen-3-yl)-2-[(1S,4S)-2,5-diazabicyclo[2.2.2]oct-2-yl]thieno[2,3-b]pyrazine-7-carboxamide;
2-(1,4-diazepan-1-yl)-N-[4-(difluoromethyl)thiophen-3-yl]thieno[2,3-b]pyrazine-7-carboxamide;
N-(4-bromothiophen-3-yl)-2-(1,4-diazepan-1-yl)thieno[2,3-b]pyrazine-7-carboxamide;
N-(4-bromothiophen-3-yl)-2-[(1S,4S)-2,5-diazabicyclo[2.2.2]oct-2-yl]thieno[2,3-b]pyrazine-7-carboxamide;
2-{[(1R,2S)-2-aminocyclohexyl]amino}-N-[4-(difluoromethyl)thiophen-3-yl]thieno[2,3-b]pyrazine-7-carboxamide;
N-(2-bromothiophen-3-yl)-2-(1,4-diazepan-1-yl)thieno[2,3-b]pyrazine-7-carboxamide;
N-(2-chlorothiophen-3-yl)-2-(1,4-diazepan-1-yl)thieno[2,3-b]pyrazine-7-carboxamide;
2-{[(1R,2S)-2-aminocyclohexyl]amino}-N-(4-bromothiophen-3-yl)thieno[2,3-b]pyrazine-7-carboxamide;
2-{[(1R,2S)-2-aminocyclohexyl]amino}-N-(2-bromothiophen-3-yl)thieno[2,3-b]pyrazine-7-carboxamide;
N-(4-cyanothiophen-3-yl)-2-(1,4-diazepan-1-yl)thieno[2,3-b]pyrazine-7-carboxamide;
2-{[(1R,2S)-2-aminocyclohexyl]amino}-N-(2-chlorothiophen-3-yl)thieno[2,3-b]pyrazine-7-carboxamide;
2-{[(1R,2S)-2-aminocyclohexyl]amino}-N-(4-cyanothiophen-3-yl)thieno[2,3-b]pyrazine-7-carboxamide;
2-[(1S,4S)-2,5-diazabicyclo[2.2.2]oct-2-yl]-N-[4-(difluoromethyl)thiophen-3-yl]thieno[2,3-b]pyrazine-7-carboxamide;
2-[(1R,4R)-2,5-diazabicyclo[2.2.2]oct-2-yl]-N-[4-(difluoromethyl)thiophen-3-yl]thieno[2,3-b]pyrazine-7-carboxamide;
2-{[(1R,2R)-2-amino-3,3-difluorocyclohexyl]amino}-N-(2-chlorothiophen-3-yl)thieno[2,3-b]pyrazine-7-carboxamide;
N-(2-chlorothiophen-3-yl)-2-[(1S,4S)-2,5-diazabicyclo[2.2.2]oct-2-yl]thieno[2,3-b]pyrazine-7-carboxamide;
N-(2-chlorothiophen-3-yl)-2-[(1R,4R)-2,5-diazabicyclo[2.2.2]oct-2-yl]thieno[2,3-b]pyrazine-7-carboxamide;
N-(2-bromothiophen-3-yl)-2-[(1S,4S)-2,5-diazabicyclo[2.2.2]oct-2-yl]thieno[2,3-b]pyrazine-7-carboxamide;
N-(2-bromothiophen-3-yl)-2-[(1R,4R)-2,5-diazabicyclo[2.2.2]oct-2-yl]thieno[2,3-b]pyrazine-7-carboxamide;
N-(4-cyanothiophen-3-yl)-2-[(1S,4S)-2,5-diazabicyclo[2.2.2]oct-2-yl]thieno[2,3-b]pyrazine-7-carboxamide;
N-(4-cyanothiophen-3-yl)-2-[(1R,4R)-2,5-diazabicyclo[2.2.2]oct-2-yl]thieno[2,3-b]pyrazine-7-carboxamide;
2-{[(1R,2R)-2-amino-3,3-difluorocyclohexyl]amino}-N-[4-(difluoromethyl)thiophen-3-yl]thieno[2,3-b]pyrazine-7-carboxamide;
2-{[(1R,2R)-2-amino-3,3-difluorocyclohexyl]amino}-N-(4-bromothiophen-3-yl)thieno[2,3-b]pyrazine-7-carboxamide;
N-(2-cyanothiophen-3-yl)-2-[(1S,4S)-2,5-diazabicyclo[2.2.2]oct-2-yl]thieno[2,3-b]pyrazine-7-carboxamide;
N-(2-cyanothiophen-3-yl)-2-[(1R,4R)-2,5-diazabicyclo[2.2.2]oct-2-yl]thieno[2,3-b]pyrazine-7-carboxamide;
2-{[(1R,2R)-2-amino-3,3-difluorocyclohexyl]amino}-N-(2-bromothiophen-3-yl)thieno[2,3-b]pyrazine-7-carboxamide;
N-(2-cyanothiophen-3-yl)-2-(1,4-diazepan-1-yl)thieno[2,3-b]pyrazine-7-carboxamide;
2-(1,4-diazepan-1-yl)-N-[2-(trifluoromethyl)thiophen-3-yl]thieno[2,3-b]pyrazine-7-carboxamide;
2-[(1S,4S)-2,5-diazabicyclo[2.2.2]oct-2-yl]-N-[2-(trifluoromethyl)thiophen-3-yl]thieno[2,3-b]pyrazine-7-carboxamide;
2-[(1R,4R)-2,5-diazabicyclo[2.2.2]oct-2-yl]-N-[2-(trifluoromethyl)thiophen-3-yl]thieno[2,3-b]pyrazine-7-carboxamide;
2-{[(1R,2S)-2-aminocyclohexyl]amino}-N-[2-(trifluoromethyl)thiophen-3-yl]thieno[2,3-b]pyrazine-7-carboxamide;
2-{[(1R,2S)-2-aminocyclohexyl]amino}-N-(2-cyanothiophen-3-yl)thieno[2,3-b]pyrazine-7-carboxamide;
2-{[(1R,2R)-2-amino-3,3-difluorocyclohexyl]amino}-N-(2-cyanothiophen-3-yl)thieno[2,3-b]pyrazine-7-carboxamide;
2-{[(1R,2R)-2-amino-3,3-difluorocyclohexyl]amino}-N-(4-cyanothiophen-3-yl)thieno[2,3-b]pyrazine-7-carboxamide;
N-(2-cyanophenyl)-2-(1,4-diazepan-1-yl)thieno[2,3-b]pyrazine-7-carboxamide;
2-{[(1R,2S)-2-aminocyclohexyl]amino}-N-[2-(trifluoromethyl)phenyl]thieno[2,3-b]pyrazine-7-carboxamide;
N-(2-bromophenyl)-2-(1,4-diazepan-1-yl)thieno[2,3-b]pyrazine-7-carboxamide;
N-(2-cyanophenyl)-2-(5,8-diazaspiro[2.6]non-5-yl)thieno[2,3-b]pyrazine-7-carboxamide;
2-[(3R)-3-aminopiperidin-1-yl]-N-(2-cyanophenyl)thieno[2,3-b]pyrazine-7-carboxamide;
N-(2-cyanophenyl)-2-[(3R)-piperidin-3-ylamino]thieno[2,3-b]pyrazine-7-carboxamide;
N-(2-cyanophenyl)-2-piperazin-1-ylthieno[2,3-b]pyrazine-7-carboxamide;
2-{[(1R,2S)-2-aminocyclohexyl]amino}-N-(2-bromophenyl)thieno[2,3-b]pyrazine-7-carboxamide;
N-(2-bromophenyl)-2-[(1S,4S)-2,5-diazabicyclo[2.2.2]oct-2-yl]thieno[2,3-b]pyrazine-7-carboxamide;
N-(2-bromophenyl)-2-[(1R,4R)-2,5-diazabicyclo[2.2.2]oct-2-yl]thieno[2,3-b]pyrazine-7-carboxamide;
2-(1,4-diazepan-1-yl)-N-[2-(trifluoromethyl)phenyl]thieno[2,3-b]pyrazine-7-carboxamide;
N-(2-chlorophenyl)-2-(1,4-diazepan-1-yl)thieno[2,3-b]pyrazine-7-carboxamide;
2-{[(1R,2S)-2-aminocyclohexyl]amino}-N-(2-chlorophenyl)thieno[2,3-b]pyrazine-7-carboxamide;
2-[(3S)-azepan-3-ylamino]-N-(2-cyanophenyl)thieno[2,3-b]pyrazine-7-carboxamide;
2-[(3R)-azepan-3-ylamino]-N-(2-cyanophenyl)thieno[2,3-b]pyrazine-7-carboxamide;
2-{[(1R,2S)-2-aminocyclohexyl]amino}-N-(2-cyanophenyl)thieno[2,3-b]pyrazine-7-carboxamide;
2-{[(1R,2R)-2-amino-3,3-difluorocyclohexyl]amino}-N-(2-bromophenyl)thieno[2,3-b]pyrazine-7-carboxamide;
N-(2-cyanophenyl)-2-[(1S,4S)-2,5-diazabicyclo[2.2.2]oct-2-yl]thieno[2,3-b]pyrazine-7-carboxamide;
N-(2-cyanophenyl)-2-[(1R,4R)-2,5-diazabicyclo[2.2.2]oct-2-yl]thieno[2,3-b]pyrazine-7-carboxamide;
N-(2-chlorophenyl)-2-[(1S,4S)-2,5-diazabicyclo[2.2.2]oct-2-yl]thieno[2,3-b]pyrazine-7-carboxamide;
N-(2-chlorophenyl)-2-[(1R,4R)-2,5-diazabicyclo[2.2.2]oct-2-yl]thieno[2,3-b]pyrazine-7-carboxamide;
2-{[(1R,2R)-2-amino-3,3-difluorocyclohexyl]amino}-N-(2-chlorophenyl)thieno[2,3-b]pyrazine-7-carboxamide;
2-{[(1R,2S)-2-aminocyclohexyl]amino}-N-[2-(difluoromethyl)phenyl]thieno[2,3-b]pyrazine-7-carboxamide;
2-(1,4-diazepan-1-yl)-N-[2-(difluoromethyl)phenyl]thieno[2,3-b]pyrazine-7-carboxamide;
2-[(1R,4R)-2,5-diazabicyclo[2.2.2]oct-2-yl]-N-[2-(difluoromethyl)phenyl]thieno[2,3-b]pyrazine-7-carboxamide;
2-{[(1R,2R)-2-amino-3,3-difluorocyclohexyl]amino}-N-(2-cyanophenyl)thieno[2,3-b]pyrazine-7-carboxamide;
2-{[(1R,2R)-2-amino-3,3-difluorocyclohexyl]amino}-N-[2-(difluoromethyl)phenyl]thieno[2,3-b]pyrazine-7-carboxamide;
N-(4-chlorothiophen-3-yl)-2-(1,4-diazepan-1-yl)thieno[2,3-b]pyrazine-7-carboxamide;
N-(4-chlorothiophen-3-yl)-2-[(1S,4S)-2,5-diazabicyclo[2.2.2]oct-2-yl]thieno[2,3-b]pyrazine-7-carboxamide;
N-(4-chlorothiophen-3-yl)-2-[(1R,4R)-2,5-diazabicyclo[2.2.2]oct-2-yl]thieno[2,3-b]pyrazine-7-carboxamide;
2-{[(1R,2S)-2-aminocyclohexyl]amino}-N-(4-chlorothiophen-3-yl)thieno[2,3-b]pyrazine-7-carboxamide; and
2-{[(1R,2R)-2-amino-3,3-difluorocyclohexyl]amino}-N-(4-chlorothiophen-3-yl)thieno[2,3-b]pyrazine-7-carboxamide;
or a pharmaceutically acceptable salt thereof.
4. A pharmaceutical composition comprising a pharmaceutical carrier and a therapeutically effective amount of a compound of claim 1 .